CliniSys Group Creates Single Brand for UK and Europe

CliniSys GroupCliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website.

The move creates a unified identity for CliniSys in the UK and MIPS on the continent and underlines the group's commitment to providing end-to-end diagnostic systems to support safe and effective healthcare systems today and to drive medical innovation in the future.

Chair and chief executive Michael Simpson said: "The CliniSys Group is the largest diagnostic laboratory IT vendor in Europe. Our combined cross-discipline expertise, spanning more than 40 years, provides our customers with solutions that span the diagnostic journey.

"We have reached this position by following our core values: customer, promises, simplicity and teamwork - a commitment to providing customers with the best possible products, services and support. From late March, we have a new look but our values remain steadfast, and we look forward to continuing to care for our customers while working with them on the innovative solutions that we will all need for the future."

In the UK, CliniSys is known for its laboratory information management system which is installed in over 50% of NHS pathology laboratories. Tests for more than 40 million patients are processed on its order communications system every year with over 70% of NHS acute trusts using ICE for GP electronic requesting.

In October 2015, CliniSys was acquired by Roper Technologies and this has enabled it to add systems from complementary suppliers, such as Sunquest Information Systems and Data Innovations. This has enabled CliniSys to offer its UK customers industry-leading, end-to-end solutions, and to think creatively about meeting the needs of pathology networks, integrated care systems, and the coming world of precision medicine.

The CliniSys name is being retained in the UK, although the logo has been refreshed. Richard Craven, CliniSys chief executive, said: "Increasingly, CliniSys and MIPS have been working more collaboratively, launching common products such as our Genomics solution and developing our Cloud architecture and strategy. We have been one company for many years, and we felt now is the right time to bring our 40 year pedigree, track record and product proposition of the CliniSys Group together in one place and under one brand."

In Europe, MIPS is best known for its general laboratory information management system or GLIMS. This is the most widely used LIMS on the continent, where it is relied on by 15,000 people operating in 17 countries and ten languages.

MIPS also has a history of innovation. It has developed GLIMS Genomics as a LIMS to meet the needs of new, high-tech genetics laboratories, and seen it successfully deployed in Poitiers University Hospital. CliniSys recently brought GLIMS Genomics to the UK, which is developing its own network of genomic laboratory hubs.

CliniSys | MIPS will be the new brand for MIPS across Europe.

Alongside its new identity, CliniSys has launched a new website with information about its products, case studies highlighting the great work being done by its customers, and blogs about the development of pathology and diagnostic laboratory IT.

The website is at: www.clinisysgroup.com. There are no changes to the group's contracts, support services, product roadmap or release schedule.

About CliniSys Group

CliniSys Group is the largest laboratory diagnostic IT vendor in Europe, with leading country market shares and an innovative and wide-reaching suite of end-to-end diagnostic solutions.

Headquartered in England, with local offices in six European countries, it has for more than 40 years been at the forefront of diagnostics workflow, order communications and information management solutions supporting radiology, cardiology and all pathology disciplines including anatomical or cellular, molecular and genetics.

These encompass the complete workflow from order, clinical decision support, collection, processing, analysis, results and reporting, through integration into the clinical workflow. CliniSys Group has built an unrivalled reputation for the deployment of complex diagnostics networks and academic centres - and is the only vendor repeatably delivering across all disciplines end to end - at scale.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...